Update to Georgia State Licensure and Medicare Processing Timelines
Feb 11, 2025
INSIGHTS
In an executive order issued on April 15th, President Trump requires the HHS Secretary to propose regulations preventing Medicare from encouraging higher drug administration volume in hospital outpatient departments rather than physician offices. These regulations seek to expand site-neutral payments, reviving an initiative undertaken by the House of Representatives in the failed 2023 Lower Costs, More Transparency Act. Health care systems and construction and architecture companies may consider assessing methods for spaces to remain flexible as these regulations, which will be proposed within the next six months, take shape.
Additionally, President Trump aims to lower Medicare outpatient hospital drug payments made to 340B hospitals. Despite similar efforts during President Trump’s first term ultimately resulting in the Supreme Court requiring CMS to reverse cuts to Medicare payment rates for 340B drugs, the renewed effort is buttressed by recent industry attacks against the 340B program (for example, manufacturer threats to employ a rebate system). The impact of this executive order on hospitals participating in the 340B program could significantly affect health system growth and strategy plans to expand and/or consolidate into suburban and rural areas.
Please note that the information provided in this release is general in nature and not intended as legal advice. Specific circumstances may vary, and we encourage clients to contact us directly for personalized assistance and further information.
Parker Hudson’s Client Alerts are published solely for the interests of friends and clients of Parker, Hudson, Rainer & Dobbs LLP and should in no way be relied upon or construed as legal advice. For specific information on recent developments or particular factual situations, the opinion of legal counsel should be sought. These materials may be considered ATTORNEY ADVERTISING in some jurisdictions.